Metraipolis › archive › dc_601bb82b4ab9
Pharmacogenomic and in silico identification of isoform-selective AKT inhibitors from Pithecellobium dulce for precision cancer therapy — Europe PMC PMID:41710547
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41710547
- DOI
- 10.3389/fphar.2025.1744408
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:04:50.135Z
- SHA-256 of the archived text
5913379c76476d86f8f07ab0ca61c82304eb0a22b8dc88cbf66e36b301c8411e- Stable URL of this page
https://metraipolis.com/documento/dc_601bb82b4ab9
How to cite
Pharmacogenomic and in silico identification of isoform-selective AKT inhibitors from Pithecellobium dulce for precision cancer therapy — Europe PMC PMID:41710547 — Europe PMC (en), https://europepmc.org/article/MED/41710547 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_601bb82b4ab9 (Metraipolis archive dc_601bb82b4ab9, sha256 5913379c76476d86f8f07ab0ca61c82304eb0a22b8dc88cbf66e36b301c8411e)
BibTeX
@misc{dc601bb82b4ab9,
title = {Pharmacogenomic and in silico identification of isoform-selective AKT inhibitors from Pithecellobium dulce for precision cancer therapy — Europe PMC PMID:41710547},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41710547},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_601bb82b4ab9; sha256 5913379c76476d86f8f07ab0ca61c82304eb0a22b8dc88cbf66e36b301c8411e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41710547. Agents can read the archived copy with the MCP tool read_document.